1-9 of 9
L. Adès
Close
Sort by
Journal Articles

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

Clinical Trials & Observations
U. Platzbecker, P. Fenaux, L. Adès, A. Giagounidis, V. Santini, A. A. van de Loosdrecht, D. Bowen, T. de Witte, G. Garcia-Manero, E. Hellström-Lindberg, U. Germing, R. Stauder, L. Malcovati, Mikkael A. Sekeres, David P. Steensma, S. Gloaguen
Journal: Blood
Blood (2019) 133 (10): 1020–1030.
https://doi.org/10.1182/blood-2018-06-857102
Published: 2019
Journal Articles

Outcome of Acute Promyelocytic Leukemia (APL) with Very High WBC Counts Treated with ATRA and Chemotherapy (CT): The European Group Experience.

C. Kelaidi, S. Chevret, S. de Botton, E. Raffoux, A. Guerci, X. Thomas, C. Gardin, A. Pigneux, A. Stoppa, T. Lamy, F. Rigal-Huguet, A. Vekhoff, S. Meyer-Monard, R. Chelo, T. Pabst, P. Chevalier, F. Maloisel, E. Deconinck, A. Ferrant, D. Bron, N. Fegueux, J. de la Serna, G. Martin, J. Cahn, N. Ifrah, B. Cassinat, H. Dombret, M.A. Sanz, Pierre Fenaux, L. Ades
Journal: Blood
Blood (2007) 110 (11): 1845.
https://doi.org/10.1182/blood.V110.11.1845.1845
Published: 2007
Journal Articles

Lenalidomide (LEN) in INT 2 and High Risk MDS with DEL 5q. Interim Results of a Phase II Trial by the GFM.

S. Burcheri, MD, T. Prebet, MD, O. Beyne-Rauzy, MD, R.M. Mbida, MD, N. Hoarau, MD, L. Legros, MD, C. Ravoet, MD, F. Dreyfus, MD, A. Stamatoullas, MD, M.P. Chaury, MD, J. Delaunay, MD, G. Laurent, MD, N. Vey, MD, L. Ades, MD, C. Gardin, MD, Pierre Fenaux, MD
Journal: Blood
Blood (2007) 110 (11): 820.
https://doi.org/10.1182/blood.V110.11.820.820
Published: 2007
Journal Articles

Disruption of Bcl-2 Heterodimerization by the BH3 Mimetic ABT-737 Restores Spontaneous Apoptosis and Induces Differentiation in High Risk MDS and AML.

L. Ades, MD, S. Boehrer, MD, T. Braun, MD, J. Grosjean, MD, C. Fabre, MD, Pierre Fenaux, MD, Guido Kroemer, MD
Journal: Blood
Blood (2007) 110 (11): 398.
https://doi.org/10.1182/blood.V110.11.398.398
Published: 2007
Journal Articles

Prognostic Factors and Response Duration in 419 MDS Treated with Erythropoietin±GCSF: The GFM Experience.

S. Park, C. Kelaidi, S. Grabar, O. Beyne-Rauzy, S. Cheze, V. Bardet, M. Escoffre-Barbe, C. Ravoet, A. Ferrant, N. Vey, H. Dombret, B. Mahe, L. Mannone, L. Legros, L. Aljassem, A. Stamatoullas, D. Vassilief, M.C. Quarre, L. Ades, V. Andrieux, S. Giraudier, S. de Botton, N. Casadevall, P. Fenaux, F. Dreyfus
Journal: Blood
Blood (2006) 108 (11): 522.
https://doi.org/10.1182/blood.V108.11.522.522
Published: 2006
Journal Articles

Is There a Role for ATRA in Combination to EPO in Lower Risk Myelodysplastic Syndrome? Preliminary Results of a Phase II Study.

L. Ades, H. Mohamed, D. Vassilief, E. Berger, B. Slama, N. Vey, R. Delarue, O. Beyne-Rauzy, A. Guerci, S. Cheze, X. Thomas, A. Stamatoullas, M. Gardembas, F. Bauduer, A. Kolb, M.C. Chaury, L. Legros, G. Damaj, F. Hamza, S. Vaultier, F. Dreyfus, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 2537.
https://doi.org/10.1182/blood.V106.11.2537.2537
Published: 2005
Journal Articles

Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials).

C. Kelaidi, L. Ades, S. Chevret, M. A. Sanz, A. Guerci, X. Thomas, S. de Botton, E. Raffoux, C. Rayon, J. de la Serna, A. Ferrant, D. Bron, H. Link, N. Fegueux, D. Bordessoule, F. Rigal-Huguet, A.M. Stoppa, A. Vekhoff, S. Meyer-Monard, M. Fey, S. Castaigne, H. Dombret, L. Degos, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 890.
https://doi.org/10.1182/blood.V106.11.890.890
Published: 2005
Journal Articles

Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL): A Comparison between French -Belgian-Swiss and Spanish Results.

L. Ades, MD, M. Sanz, MD, S. Chevret, MD, S. De Botton, MD, G. Martin, MD, E. Raffoux, MD, E. Vellenga, MD, A. Guerci, MD, M. Gonzalez, MD, A. Pigneux, MD, C. Rayon, MD, A.M. Stoppa, MD, J. De la Serna, MD, T. Pabst, MD, S. Meyer-Monard, MD, R. Parodi, MD, J. Bergua, MD, F. Rigal-Huguet, MD, A. Vekhoff, MD, S. Negri, MD, N. Fegueux, MD, A. Ferrant, MD, D. Bron, MD, H. Dombret, MD, L. Degos, MD, P. Fenaux, MD
Journal: Blood
Blood (2005) 106 (11): 544.
https://doi.org/10.1182/blood.V106.11.544.544
Published: 2005
Journal Articles

Is ARAC Required in the Treatment of Newly Diagnosed APL? Results of a Randomized Trial (APL 2000).

L. Ades, E. Raffoux, S. Chevret, S. de Botton, A. Guerci, A. Pigneux, A.M. Stoppa, T. Lamy, F. Rigal-Huguet, A. Vekhoff, T. Pabst, S. Meyer-Monard, F. Maloisel, E. Deconinck, D. Caillot, N. Gratecos, J.J. Sotto, A. Ferrant, P. Turlure, X. Thomas, N. Fegueux, P. Brault, O. Reman, P. Chevallier, P. Travade, V. Leblond, G. Leverger, A. Stamatoullas, C. Pautas, B. Beve, C. Chomienne, H. Dombret, L. Degos, P. Fenaux
Journal: Blood
Blood (2004) 104 (11): 391.
https://doi.org/10.1182/blood.V104.11.391.391
Published: 2004